chrX-54443461-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_058163.3(TSR2):āc.234T>Cā(p.Asp78=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00434 in 1,205,507 control chromosomes in the GnomAD database, including 15 homozygotes. There are 1,772 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0046 ( 0 hom., 166 hem., cov: 23)
Exomes š: 0.0043 ( 15 hom. 1606 hem. )
Consequence
TSR2
NM_058163.3 synonymous
NM_058163.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.69
Genes affected
TSR2 (HGNC:25455): (TSR2 ribosome maturation factor) The protein encoded by this gene appears to repress the transcription of NF-kappaB and may be involved in apoptosis. Defects in this gene are a cause of Diamond-Blackfan anemia. [provided by RefSeq, Oct 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant X-54443461-T-C is Benign according to our data. Variant chrX-54443461-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 709009.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-54443461-T-C is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=1.69 with no splicing effect.
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.00431 (4716/1093692) while in subpopulation MID AF= 0.0274 (113/4119). AF 95% confidence interval is 0.0233. There are 15 homozygotes in gnomad4_exome. There are 1606 alleles in male gnomad4_exome subpopulation. Median coverage is 29. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 166 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TSR2 | NM_058163.3 | c.234T>C | p.Asp78= | synonymous_variant | 3/5 | ENST00000375151.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TSR2 | ENST00000375151.5 | c.234T>C | p.Asp78= | synonymous_variant | 3/5 | 1 | NM_058163.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00465 AC: 520AN: 111760Hom.: 0 Cov.: 23 AF XY: 0.00489 AC XY: 166AN XY: 33924
GnomAD3 genomes
AF:
AC:
520
AN:
111760
Hom.:
Cov.:
23
AF XY:
AC XY:
166
AN XY:
33924
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00450 AC: 790AN: 175563Hom.: 2 AF XY: 0.00482 AC XY: 291AN XY: 60431
GnomAD3 exomes
AF:
AC:
790
AN:
175563
Hom.:
AF XY:
AC XY:
291
AN XY:
60431
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00431 AC: 4716AN: 1093692Hom.: 15 Cov.: 29 AF XY: 0.00447 AC XY: 1606AN XY: 359390
GnomAD4 exome
AF:
AC:
4716
AN:
1093692
Hom.:
Cov.:
29
AF XY:
AC XY:
1606
AN XY:
359390
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00463 AC: 518AN: 111815Hom.: 0 Cov.: 23 AF XY: 0.00488 AC XY: 166AN XY: 33989
GnomAD4 genome
AF:
AC:
518
AN:
111815
Hom.:
Cov.:
23
AF XY:
AC XY:
166
AN XY:
33989
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
TSR2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 10, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Diamond-Blackfan anemia 14 with mandibulofacial dysostosis Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | May 16, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at